Oppenheimer Adjusts Price Target on IDEX to $265 From $260, Maintains Outperform Rating

Oppenheimer has increased its price target for IDEX (IEX) to $265 from $260, while reiterating an Outperform rating on the stock. This adjustment comes amidst a series of analyst updates for IDEX, including price target changes from BNP Paribas, Stifel, BMO Capital, and Baird, following the company's Q2 2026 earnings announcement. IDEX reported higher adjusted earnings and revenue for the second quarter and raised its 2026 adjusted EPS outlook, driven by strong demand from AI data centers.